Drawing for STEXARC

USPTO serial 78494610

STEXARC

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
MAYES, LAURIE ANN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STEXARC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agentsABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 7, 2006ABN5ABANDONMENT - AFTER PUBLICATION
Mar 7, 2006EXARTEAS EXPRESS ABANDONMENT RECEIVED
Feb 21, 2006NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 29, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 9, 2005NPUBNOTICE OF PUBLICATION
Oct 13, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 7, 2005ALIEASSIGNED TO LIE
Oct 3, 2005CNEAEXAMINERS AMENDMENT MAILED
Oct 2, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2005CNEAEXAMINERS AMENDMENT -WRITTEN
Sep 17, 2005ACECAMENDMENT FROM APPLICANT ENTERED
Sep 12, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2005CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 25, 2005CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 17, 2005DOCKASSIGNED TO EXAMINER
Oct 14, 2004NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance